Zobrazeno 1 - 10
of 51 981
pro vyhledávání: '"John A"'
Autor:
David H. Johnson, Roy S. Herbst, Corey J. Langer, Louis Fehrenbacher, William Novotny, Eric Holmgren, Jacques Gaudreault, John Nemunaitis, David M. Jablons, Fairooz F. Kabbinavar, Russell F. DeVore, Lisa A. Damico
Publikováno v:
Journal of Clinical Oncology. 41:2305-2312
Purpose To investigate the efficacy and safety of bevacizumab plus carboplatin and paclitaxel in patients with advanced or recurrent non-small-cell lung cancer. Patients and Methods In a phase II trial, 99 patients were randomly assigned to bevacizum
Autor:
John K. Choi, Paul E. Mead
Publikováno v:
Clinics in Laboratory Medicine. 43:115-125
Minimal residual disease detection provides critical prognostic predictor of treatment outcome and is the standard of care for B lymphoblastic leukemia. Flow cytometry-based minimal residual disease detection is the most common test modality and has
Autor:
Jennifer Leng, Jeralyn Cortez, Lei Lei, Florence Lui, Francesca Gany, Shu Fang Lei, John Capua
Publikováno v:
J Cancer Educ
BACKGROUND: Racial/ethnic minorities face stark inequalities in lung cancer incidence, treatment, survival, and mortality compared with U.S. born non-Hispanic Whites. Lung cancer screening (LCS) with low-dose computed tomography (LDCT) is effective a
Autor:
Jordan M. Winter, John Shanahan, Lee M. Ocuin, Jeffrey M. Hardacre, John B. Ammori, Luke D. Rothermel, Jonathan J. Hue, Sarah C. Markt, Ravi Kumar Kyasaram, Kavin Sugumar
Publikováno v:
The American Journal of Surgery. 223:927-932
Background Weight changes during neoadjuvant chemotherapy (NAC) for pancreatic cancer (PDAC) are not well studied. We hypothesized that weight loss may predict poor outcomes. Methods Weight change from NAC initiation to pancreatectomy was grouped: ga
Autor:
John Kuruvilla, Anca Prica, Robert Kridel, Sita Bhella, Farheen Manji, Vishal Kukreti, Michael Crump
Publikováno v:
Leukemia & Lymphoma. 63:3402-3408
Interim imaging with computed tomography (iCT) to assess response is common during frontline chemoimmunotherapy for follicular lymphoma (FL), but there is little evidence of its utility. We retrospectively reviewed outcomes of iCT in 190 patients wit
Autor:
Arsalan Tariq, Ian Vela, Sima P. Porten, Elizabeth D. Williams, John Yaxley, Peter C. Black, Amy E. McCart Reed, Andrew Morton, Matthew J. Roberts
Publikováno v:
European Urology Focus. 8:1256-1269
Context Staging, restaging, and surveillance of urothelial carcinoma (UC) is challenging due to suboptimal accuracy of standard of care imaging modalities. Prostate-specific membrane antigen (PSMA) imaging may serve to improve characterisation of UC.
Autor:
John M. Mariadason, Paul C. Boutros, Gavin M. Wright, Mun Sem Liew, Thomas John, Aparna Jayachandran, Anderly C. Chueh, Maud H.W. Starmans, Stephen Barnett, Prudence A. Russell, Marzena Walkiewicz
Publikováno v:
Oncotarget
Oncotarget, vol 8, iss 43
Oncotarget, vol 8, iss 43
Cancer-Testis antigens (CTA) are immunogenic molecules with normal tissue expression restricted to testes but with aberrant expression in up to 30% of non-small cell lung cancers (NSCLCs). Regulation of CTA expression is mediated in part through prom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3c9cbe6ee2025e8af7e3a77b76257a
Autor:
Alain Tremblay, Christian Couture, John R. Goffin, Paul MacEachern, Zhaolin Xu, Annette McWilliams, Dean A. Regier, Garth Nicholas, Kayvan Amjadi, Frances A. Shepherd, William K. Evans, Paul Burrowes, Ian Cromwell, Jean M. Seely, Glenwood D. Goss, Michael R. Johnston, Rick Bhatia, John Yee, Martin C. Tammemägi, Richard J. Finley, Serge Puksa, Heidi C. Roberts, Ming-Sound Tsao, John R. Mayo, Sonya Cressman, Stephen Lam, Simon Martel, Natasha B. Leighl, Corneliu Bolbocean, Kazuhiro Yasufuku, Stefan J. Urbanski, S. Atkar-Khattra, Harmanjatinder S. Sekhon, Diana N. Ionescu, Stuart Peacock, Daria Manos, Geoffrey Liu, Wan C. Tan, Don D. Sin, Kamyar Soghrati, John C. English, David M. Hwang, Jean-Claude Cutz
Publikováno v:
Journal of Thoracic Oncology
Background It is estimated that millions of North Americans would qualify for lung cancer screening and that billions of dollars of national health expenditures would be required to support population-based computed tomography lung cancer screening p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b529ba04cc888b464bdfc93d33eddb9
https://doi.org/10.1097/jto.0000000000000283
https://doi.org/10.1097/jto.0000000000000283
Autor:
Ariadna Juarez-Garcia, John C O'Donnell, John R. Penrod, Mats Rosenlund, Simon Ekman, Jens Benn Sørensen, Anne Mette Kejs, Pia Horvat, L. Lacoin, Odd Terje Brustugun, Dony Patel, M. Daumont
Publikováno v:
Sørensen, J B, Horvat, P, Rosenlund, M, Kejs, A M, Patel, D, Juarez-Garcia, A, Lacoin, L, Daumont, M J, Penrod, J R, O'donnell, J C, Brustugun, O T & Ekman, S 2022, ' Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015) : SCAN-LEAF study ', Future Oncology, vol. 18, no. 2, pp. 205-214 . https://doi.org/10.2217/fon-2021-0746
Aim: To describe initial treatment patterns and survival of patients diagnosed with non-small-cell lung cancer (NSCLC) in Denmark, before immune checkpoint inhibitor and later-generation tyrosine kinase inhibitor use. Patients & methods: Adults diagn
Autor:
Marjorie E Zettler, Sanya Sharma, Jonathan Kish, Shreenath Sridharan, Amy W. Valley, John Showalter, John Frownfelter, Sibel Blau, Kelly A Miller, Ajeet Gajra
Publikováno v:
JCO Oncology Practice. 18:e80-e88
PURPOSE: For patients with advanced cancer, timely referral to palliative care (PC) services can ensure that end-of-life care aligns with their preferences and goals. Overestimation of life expectancy may result in underutilization of PC services, co